DailyIQ
|
Last updated4 minutes ago

MDGL·Madrigal Pharmaceuticals Inc.

$511.96
-4.78 (-0.93%)
Overnight$516.74+4.78 (+0.93%)
High
$517.00
Open
$515.89
Market Cap
11.73B
52W High
$615.00
Low
$507.17
P. Close
$511.96
P/E
-
52W Low
$392.97
Fwd P/E
53.69
DailyIQ Est.
-
Inst. Ownership
-
Short Interest
8.66%
Technical Score (1D)
82
BUY
News Sentiment
47
MIXED
Madrigal Pharmaceuticals announced that its Compensation Committee approved the grant of 4,676 time‑based restricted stock units to 13 non‑executive hires under the 2025 Inducement Plan, with vesting spread over four years and contingent on continued employment. The move satisfies Nasdaq Listing Rule 5635(c)(4) and signals the company’s intent to strengthen its talent pool for the MASH therapeutic pipeline. By bringing in new hires, Madrigal is positioning itself to accelerate development and commercialization of its pipeline assets, which could shorten the time to market for future products. The grant also reflects a broader strategy to align employee incentives with long‑term shareholder value, potentially improving retention and performance. For the next 1–10 trading days, the market will likely monitor how these hires integrate into ongoing projects and whether any immediate milestones are announced. Watch for any subsequent updates on pipeline progress or product launch timelines that could be influenced by the expanded team. Additionally, keep an eye on any changes in the company’s guidance or capital allocation that might accompany the new talent acquisition.

EPS

EstBeatMiss
$-5.54$-4.28$-3.02$-1.76$-0.51Q3'25Q3'26
QtrEstActual+/−
Q3'26$-1.09 - -
Q3'25$-1.99$-4.96-148.8%

Revenue

EstBeatMiss
$270M$308M$346M$384M$423MQ3'25Q3'26
QtrEstActual+/−
Q3'26$405M - -
Q3'25 - $287M -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

MDGL Stock Snapshot

MDGL is currently trading at $516.74, giving Madrigal Pharmaceuticals Inc. a market cap of 11.73B. Today's range spans $507.17–$517.00, with shares opening at $515.89 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 47/100.

Over the past year MDGL has traded between $392.97 and $615.00 - the current price is +31.5% off the 52-week low and -16.0% from the high.

Dividend-paying the broader market stocks at the large-cap level tend to attract a different buyer mix than pure growth names - and MDGL (11.73B market cap) with a BUY read (82/100) and neutral sentiment (47/100) benefits from both income-oriented and growth-oriented flows. Price: $516.74 (in the middle of its 52-week range in $392.97–$615.00). When technical momentum aligns with that dual-buyer base, the price path tends to be more durable than single-buyer-type momentum trades.

What makes MDGL's BUY setup (82/100) particularly actionable at 11.73B in the broader market capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $516.74 (in the middle of its 52-week range in $392.97–$615.00), with sentiment running neutral at 47/100, the setup rewards conviction-sized positioning more than it does speculative small bets.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles